Dublin, Dec. 19, 2017 -- The "US Fertility Clinics Market" report has been added to Research and Markets' offering.
This research report categorizes the US fertility clinics market by segments. These segments include assisted reproductive technology, diagnostic services and surgeries.
Report Includes
- An overview of the US market for fertility clinics
- Analyses of global market trends, with data from 2012 through 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Examination of the critical market characteristics of the fertility market, including technological developments, the value chain, market dynamics, and key market trends
- Market breakdowns by diagnostics services and assisted reproductive technology
- Coverage of major government regulations, recent industry developments, and the competitive landscape
- Information on leading companies, including their services and recent developments
Key Topics Covered:
1: Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Methodology
- Geographic Breakdown
2: Summary and Highlights
- Table Summary : US Fertility Clinic Services Market, Through 2022
- Figure Summary : US Fertility Clinic Services Market, 2017-2022
3: Market Characteristics
- Service Definition
- Application
- Cause of Infertility
- Stages of Fertility Treatment
- Market Value Chain & Key Participants
- Drivers
- Restraints
- Key Market Trends
4: Market Historic Growth and Forecast
- Historic Market Growth
- Forecast Market Growth
5: US Fertility Clinics Market Segmentation
- Fertility Clinics in the US. Market, By Segment, 2016
- Fertility Clinics Volume in the US Market, By Segment, 2016
6: US Fertility Drugs Market
7: Regulatory Landscape
- Regulations Regarding IVF in the United States
- Regulations Regarding IUI in the United States
- Regulations Regarding Surrogacy in the United States
- Regulations Regarding Egg Freezing in the United States
- Regulations Regarding Sperm Donation in the United States
8: Recent Industry Developments
- News and Developments
- Mergers and Acquisitions
9: Competitive Landscape
- Competitor Market Share
- Brief Company Profiles of the Leading Companies in the Market
10: Conclusions and Recommendations
- Emotional Support
- IVF should be the Last Option, Not First
- Minimizing Health Risks
- Access to ART
11: Appendix A: Unmet Needs
- Need for Low Cost Treatments
- Need for Low Risk Treatments
- Need for Accessible Fertility Services
12: Appendix B: Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/h73mzj/us_fertility?w=12
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hospital Management


CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 



